TGF-β blocks T cell proliferation, inhibits differentiation of Th1 (T helper class 1) cells and CTLs (cytotoxic T lymphocytes), and promotes expansion as well as maintenance of CD4+CD25+ regulatory T cells that can inhibit GVHD [42,70–77]. The gene discussed is CD4; the disease is graft versus host disease.